{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:53:56Z","timestamp":1791327236341,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["SGZ-2018-12361"],"award-info":[{"award-number":["SGZ-2018-12361"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 109-2314-B-002-052-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-002-052-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-002-074-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-002-074-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.alit.2026.04.009","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:31:10Z","timestamp":1781220670000},"page":"602-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduced conjunctival goblet cells and altered tear film stability predispose atopic dermatitis patients to develop dupilumab-associated ocular surface disease and show a Th1\/innate immune response in tear fluid"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-8997","authenticated-orcid":false,"given":"Yung-Tsu","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-912X","authenticated-orcid":false,"given":"Tom C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1538-2414","authenticated-orcid":false,"given":"Wei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-7347","authenticated-orcid":false,"given":"Hsiao-Sang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-3279","authenticated-orcid":false,"given":"Chia-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 pt 2","key":"10.1016\/j.alit.2026.04.009_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jfma.2020.06.008","article-title":"Taiwanese Dermatological association consensus for the management of atopic dermatitis: a 2020 update","volume":"120","author":"Chan","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.alit.2026.04.009_bib2","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jaip.2024.04.008","article-title":"Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate to severe atopic dermatitis","volume":"12","author":"Cho","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2026.04.009_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaad.2020.11.037","article-title":"Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: a systematic review and meta-analysis","volume":"85","author":"Ravn","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2017.03.003","article-title":"Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis","volume":"77","author":"Thyssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jdv.17832","article-title":"Factors associated with ocular surface disease and severity in adults with atopic dermatitis: a nationwide survey","volume":"36","author":"R\u00f8nnstad","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2026.04.009_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/all.14080","article-title":"Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: first clinical and biomarker results from the BioDay registry","volume":"75","author":"Ari\u00ebns","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.009_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40257-025-00952-w","article-title":"The safety data of dupilumab for the treatment of moderate-to-severe atopic dermatitis in infants, children, adolescents, and adults","volume":"26","author":"Langley","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.01.034","article-title":"Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment","volume":"6","author":"Wollenberg","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2026.04.009_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","author":"Akinlade","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/jdv.17981","article-title":"Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review","volume":"36","author":"Neagu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2026.04.009_bib11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/bjd.17538","article-title":"Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis","volume":"180","author":"Bakker","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/all.15717","article-title":"Dupilumab-associated ocular surface disease in atopic dermatitis patients: clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis","volume":"78","author":"Achten","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.009_bib13","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/all.15326","article-title":"IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro","volume":"77","author":"Hansen","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.009_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/all.16045","article-title":"Dupilumab-associated ocular surface disease is characterized by a shift from Th2\/Th17 toward Th1\/Th17 inflammation","volume":"79","author":"Thormann","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2026.04.009_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.alit.2026.04.009_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/ICO.0000000000002692","article-title":"Evaluation of clinical efficacy and safety of prolonged treatment of vernal and atopic keratoconjunctivitis using topical tacrolimus","volume":"41","author":"Hirota","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.alit.2026.04.009_bib17","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/aos.12516","article-title":"Effect of non-invasive tear stability assessment on tear meniscus height","volume":"93","author":"Koh","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.alit.2026.04.009_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00003226-198801000-00012","article-title":"Impression cytology","volume":"7","author":"Nelson","year":"1988","journal-title":"Cornea"},{"key":"10.1016\/j.alit.2026.04.009_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/ACI.0b013e3283645899","article-title":"The ocular surface epithelial barrier and other mechanisms of mucosal protection","volume":"13","author":"Mantelli","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2026.04.009_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaad.2019.07.031","article-title":"Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: a multi-institution retrospective chart review","volume":"85","author":"Waldman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2021.09.029","article-title":"Dupilumab-induced ocular surface disease: a systematic review","volume":"86","author":"Fachler","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2026.04.009_bib22","first-page":"692","article-title":"Neurotrophic factors in the human cornea","volume":"41","author":"You","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.alit.2026.04.009_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biocel.2008.07.018","article-title":"Monocyte chemoattractant protein-1: a key mediator in inflammatory processes","volume":"41","author":"Melgarejo","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.alit.2026.04.009_bib24","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1167\/iovs.06-1226","article-title":"Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation","volume":"48","author":"R\u00edos","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.alit.2026.04.009_bib25","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/ijms25031369","article-title":"A systematic review of tear vascular endothelial growth factor and external eye disease","volume":"25","author":"Chan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2026.04.009_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","article-title":"The corneal fibrosis response to epithelial-stromal injury","volume":"142","author":"Torricelli","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.alit.2026.04.009_bib27","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s10067-016-3527-z","article-title":"The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.alit.2026.04.009_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ICO.0000000000001904","article-title":"Evaluation of chemokine mRNA expression to assess allergic inflammation of the ocular surface in chronic allergic conjunctival diseases","volume":"38","author":"Hiroshi","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.alit.2026.04.009_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41385-020-0288-4","article-title":"IL-33\/ST2\/IL-9\/IL-9R signaling disrupts ocular surface barrier in allergic inflammation","volume":"13","author":"Hu","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.alit.2026.04.009_bib30","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1167\/iovs.16-20789","article-title":"T cell-derived granulocyte-macrophage colony-stimulating factor contributes to dry eye disease pathogenesis by promoting CD11b+ Myeloid cell maturation and migration","volume":"58","author":"Dohlman","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.alit.2026.04.009_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100340","article-title":"Persistent neutrophil infiltration and unique ocular surface microbiome typify dupilumab-associated conjunctivitis in patients with atopic dermatitis","volume":"4","author":"Patra","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.alit.2026.04.009_bib32","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.1128","article-title":"Identification of risk factors for dupilumab-associated ocular surface disease in patients with atopic dermatitis","volume":"102","author":"Achten","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2026.04.009_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cea.14461","article-title":"Ocular surface disease in moderate-to-severe atopic dermatitis patients and the effect of biological therapy","volume":"54","author":"Achten","year":"2024","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2026.04.009_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cea.70025","article-title":"Dupilumab-associated ocular surface disease in paediatric atopic dermatitis patients: results from the BioDay registry","volume":"55","author":"van der Rijst","year":"2025","journal-title":"Clin Exp Allergy"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893026000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893026000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:47:27Z","timestamp":1791326847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893026000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1323893026000560"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2026.04.009","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced conjunctival goblet cells and altered tear film stability predispose atopic dermatitis patients to develop dupilumab-associated ocular surface disease and show a Th1\/innate immune response in tear fluid","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2026.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}